A Randomized Phase II Trial of Two Dose Schedules of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer.

Trial Profile

A Randomized Phase II Trial of Two Dose Schedules of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Apr 2010

At a glance

  • Drugs Carboplatin; Cetuximab; Paclitaxel
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors ImClone Systems
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 13 Oct 2009 Actual initiation date changed from Dec 2004 to Nov 2004 as reported by ClinicalTrials.gov.
    • 01 Oct 2008 Actual number of patients enrolled was 160 according to Clinicaltrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top